chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The report to VAERS provides the following narrative. No information was provided regarding medical history, concomitant medications and concurrent disease of the patient. Patient had been receiving FLUMIST (intranasal) started on 15-Oct-2009. Gradually developing ascending weakness culminating in admission to hospital and diagnosis of Guillain-Barre syndrome. Child has been sick 2 weeks, complained of right hip pain the day prior to admission. Now complains of weakness in legs and arms, wide gait. Absent ankle/knee jerks. Tired, irritable, stumbling and falling. IVIG administration. Dehydration. Decreased weakness, improved ambulation. Discharged. Action taken with FLUMIST was unknown. The outcome of the event of Guillain-Barre syndrome was unknown. The reporter assessed the event of Guillain-Barre syndrome to be serious with seriousness criteria of Life threatening and Hospitalised.
Patient emailed us that she has been having pain in the right shoulder since the Influenza Injection was administered on 11/8/2022. She advised that she has seen an orthopedist and was diagnosed with SIRVA. She did not indicate the doctors name in the email.
sitting in car in 30 min line, got dizzy, thought was because of playing on phone, then mouth went numb, tongue swelling and lower jaw numbmess.  Notified the MD's taken out of car had BP given claritin was being monitored and BP kept rising given epipen.  The epipen helped felt swelling go down started to relax.  Taken by ambulance to hospital. Treated with Steroid and benadryl and prevacid. No breathing treatments given epipens there and taken home prescribed.  after he went home sore arm, dizzy, tired then symptoms started to come back took steroids and bendadryl which helped the reaction to go away. sx lasted 2-3 days. mild towards the end.
Case was vaccinated and boosted x1 against Covid, as of September 2021, then was hospitalized for COvid in February of 2022.   Hospitalized at:  Hospital.  Pneumonia due to COVID-19 virus Symptoms started 1/25/22, tested positive 1/27/22. Received molnupiravir before admission. Vaccinated but not boosted, and noted history of MDS likely decreased vaccine effectiveness. CXR and CT with multifocal patchy airspace opacities consistent with a viral pneumonia. Had increasing O2 needs requiring HFNC so received tocilizumab 2/12. She completed her initial steroid course 2/17. Then restarted steroids 2/19 with the ongoing high O2 needs. Fortunately her O2 needs then started to improve. Her CRP down trended. Patient was on 3L NC for the 2 days prior to discharge and felt well. She was discharged home with supplemental O2 and can wean it as able. She was also prescribed a dexamethasone taper due to the severity of her covid-19 pneumonia. She was out of isolation at the time of discharge.  Acute respiratory failure with hypoxia  Secondary to covid-19 pneumonia. Also had a high BNP and was diuresed 2/17 and 2/18 but that did not improve her O2 needs. Echo 12/20 showed moderate pHTN which also contributes to hypoxia. Treated covid as noted above. On 3L at the time of discharge, continue to wean as able
Covid 19; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Covid 19) in an adult male patient who received SPIKEVAX NOS (SPIKEVAX NOS) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid 19). At the time of the report, COVID-19 (Covid 19) had resolved.        The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown.   For SPIKEVAX NOS (SPIKEVAX NOS) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient also tested positive for COVID-19 after being on an airplane 6 months after he received Moderna. No treatment medications were provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-741662 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-741662:Son case
blister appeared under eye-lasted 2hr & went away;happened 1hr p/vax; Per HCP report-On 6/8/01, Mother reported she thought reaction of eyelid swelling on 6/28/1999 not due to Hep B #1 but due to Motrin/Advil medication she had given the child after the vaccination. The eyelid swelling occurred again after another dose of Advil/Motrin. At mom's request, Hep B#2 given to patient. Patient thus far had no reactions to Hep B #2.
3 rd day headache slight coughing 4 day tingling in my tongue increased coughing and wheezing  6th  day increased tiredness low grade fever 99.4 coughing and wheezing slept most of the day  7 th day headache some coughing
patient was talked into the flu shot once and got sick; Initial information was received on 20-Oct-2020 regarding an unsolicited valid non-serious case from a consumer via social media.  This case is linked to case 2020SA297294 (same reporter).  This case involves a female patient of an unknown age who was talked into the flu shot once and got sick (illness), while she was treated with influenza vaccine.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was not reported.  On an unknown date, the patient received influenza vaccine [lot number: unknown and expiration date: unknown] at an unknown dose via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date (latency: unknown) after starting the suspect vaccine therapy, the patient was talked into the flu shot once and got sick (illness).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case.
This spontaneous report as received from a other refers to a patient of unknown age. On 11-FEB-2013 the patient was vaccinated with a first dose of GARDASIL 120 Y, dose, indication, site and route of administration not reported). It was reported that (on 01-NOV-2013) the patient would now like to receive the second dose of GARDASIL. No adverse event reported. Additional information has been requested.
Swollen lips, face, hands, and difficulty breathing. Taken to ER-IV Benadryl, steroid, and possibly other medications.
patient was administered an expired booster dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was administered an expired booster dose) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was administered an expired booster dose). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (patient was administered an expired booster dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant and treatment medications are provided by the reporter. Moderna vaccine given expired in December. But it turned out it expired on 27-Oct-2021. Unfortunately 16 doses were given on 29-Oct-2021 in the pharmacy.is possible that more people got doses from vials with this lot number in another pharmacy of the same chain.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A, 015M20A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021 at 10:59 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021 at 9:18 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Unknown      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment medication reported.
Patient experienced nausea/vomiting, throat tightening, shortness of breath, numbness and tingling at the injection site, and inability to maintain consciousness.  She required medical assistance and was treated for anaphylaxis.  These symptoms appeared within 30 minutes of the injection and patient was fully recovered of symptoms after medical treatment and a period of about 6-8 hours of rest.
Patient became lethargic, was vomiting, and had diarrhea. She slept for 3 days straight (Friday through Sunday), waking only for very short periods. She vomited everything she ate or drank, including water. Vomiting started Friday at 2am and ended Sunday at 9am. Diarrhea started Sunday morning and lasted until Tuesday. Patient also complained her legs hurt (both legs) and would cry from the pain. No one else in our household of 5 got sick. Our household includes another child, age 4. We contacted our doctor and had a phone consultation and monitored patient closely for dehydration.
foot pain which he described as it feels like he is standing on small pebbles or ball Barings; suffered joint pain in every joint in his body; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (foot pain which he described as it feels like he is standing on small pebbles or ball Barings) and ARTHRALGIA (suffered joint pain in every joint in his body) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 083B21a and 007B21a) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (foot pain which he described as it feels like he is standing on small pebbles or ball Barings) and ARTHRALGIA (suffered joint pain in every joint in his body). At the time of the report, PAIN IN EXTREMITY (foot pain which he described as it feels like he is standing on small pebbles or ball Barings) outcome was unknown and ARTHRALGIA (suffered joint pain in every joint in his body) had resolved.            No concomitant medications were reported.  No Treatment medications were reported   This case was linked to MOD-2021-262831 (Patient Link).
HUGE swelling, redness the size of a canalope on my arm.Hot to the touch & throbbing like someone punched me really hard at injection site. The redness lasted a few weeks the pain and throbbing lasted over 9 months with a constant throbbing the whole time! I also lost most use of my arm I couldn't sleep on it or raise it above my chest level without causing more pain. I lost muscle strength as well and couldn't lift with that arm for 6 months. To THIS day it still hurts if I move my arm or hold my arm a certain way! The throbbing finally stopped but it never went back to feeling normal. If I raise my arm above chest level it hurts a lot If I do anything that requires I use muscle strength like use that arm to lift myself It hurts at the site of injection as it has since the injection. I WOULD like to know what is going on and WHY the side effects/pain muscle strength loss have lasted so long & what can I do to get my arm back to normal.
I had a little cough that I did not think much of because I have asthma. I went out of town on the 9th and I still had the cough. The next day I was feeling out of breath and out of sorts. The next morning on the 11th, I still wasn't feeling right so we decided to take the home COVID-19 which was positive. We came and called my doctor and she prescribed PAXLOVID. I took the first dose that evening. My symptoms were mild. I never had a fever. I can't say that the PAXLOVID helped since I really was not that sick. My symptoms did not get worse though. I do still have a slight cough but it could be seasonal allergies.
35 minutes after receiving the shot, I went into a cluster headache.  My last cluster headache was 7 years ago and I learned to treat it with oxygen therapy.  I have now had about 10 cluster headaches since the injection.  Because I have a tank of oxygen, I shut them down for about 2 weeks at a time.  When I ran out of oxygen and had to wait for the tank to get refilled, I got headaches 4 nights in a row for about 30-45 minutes each.  On the 4th night (this week), I had oxygen again and was able to shut down the headache as it started to happen and haven't had one again since.
lost appetite; so tired, thought could not get out of bed; Big/ huge clots, came out in a spit; had 3 nose bleeds; A spontaneous report was received from a 77-year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced 3 nose bleeds/ Epistaxis, big/huge clots, clot came out in a spit/ Thrombosis, tiredness/ Fatigue, and loss of appetite/ Decreased appetite.  The patient's medical history was not provided. No concomitant product use was reported.  On 12 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.   On 13-Feb-2021, the patient experienced 3 nose bleeds with huge blood clots. The bleeding was persistent throughout the day, stopping at the intervals and later on the same day it was reported the patient had a huge clot come out in spit. On 14 Feb 2021, the patient was tired, could not get out of bed, and had lost appetite. On 18-Feb-2021, the patient woke up feeling normal.  Treatment information was unknown.  Action taken with mRNA-1273 in response to the events was not provided.  The outcomes of the events were not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pt recived Pfizer 24 days ago, and received Janssen today. Instructed to file VAERS report due to admin error and Pt received shot within 28 day window.
One very sharp, shooting pain from shoulder, up my neck about 12 hours after vaccination woke me from sleep. I began to feel generally unwell, as I expected and  had experienced in the past. Followed by severe pain on left side of my face, teeth throbbed like they were all abbessed, pain went to my ear, my eye and left side of my nose.  SEVERE pain.. This lasted about 24 hours then totally disappeared.
Blister formed the days following vaccination. Blister fell off but area remained scabbed over, inflamed and painful. Patient reported adverse event to pharmacy 4.5 months after vaccine and the area is still painful and inflamed. Patient believes that it may be infected.
Case previously recorded as MA2009-5154. Initial case report received from a physician, via Novartis Medical Communication on 20 NOV 2009. A 22-month-old male patient was vaccinated with S-OIV FOCETRIA (batch no. 102124P1, expiration date 31 MAR 2010) i.m. on 13 NOV 2009. No adverse event was reported. MedCom reference no.: NA09-008308.
Chest pain, dizziness, light headedness, severe exhaustion/fatigue, headache
Pt was observed for 15 minutes after immunization and reported no immediate symptoms. That night, the patient ate salmon and mashed pototaes at 630pm. He reports arund 930pm, he developed stomach ache and one episode of diarrhea.  Patient reports subsequent mild constriction in his throat and acute nasal congestion. Patient also reported acute onset of wheezing. He initially took his albuterol inhaler and took a puff of of Dulera without symptom improvement. He administered epinephrine IM at that point with immediate symptom improvement. He reports nasal congestion and wheezing resolved. Patient monitored symptoms at home. He did not seek medical attention. Unsure if reaction was related to salmon or COVID 19 vaccine. Patient will be assessed in clinci for a formal salmon oral challenge in the clinic. Patient will receive the 2nd shot COVID 19 vaccine and will bring epi pen with him to the clinic.
swollen lymph nodes on my left side which was the side I got the vaccine on (swollen lymph node under my left armpit, swollen lymph node near my left clavicle bone); Extreme soreness at injection site; This is a spontaneous report from a contactable other hcp (patient). A 31-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL3247), dose 1 via an unspecified route of administration, administered in Arm Left on 20Jan2021 (at the age of 31-year-old) as dose 1, single for covid-19 immunisation. The patient medical history included none. No concomitant medications. Patient had no allergies. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Feb2021, 12 days after vaccination the patient experienced swollen lymph nodes on her left side which was the side she got the vaccine on (swollen lymph node under my left armpit, swollen lymph node near my left clavicle bone), extreme soreness at injection site. No treatment was taken as a result of events. The outcome of the events were recovering.   Follow-up attempts completed. No further information expected.
I experienced nothing but arm soreness and some fatigue after the second dose. Four months after the second dose I got a Prodromal Headache which progressed to Herpes Zoster which was isolated to my face. I had to get eye drops for my eye. It has healed with treatment but I have some scarring.
Pt recvd 1st dose of Hep B vax on 5DEC90 & the next day exp burning & itching of scalp & redness & burning around ears; 2 days p/vax pt exp generalized pruritic rash which persisted intermittently x 2 wks & then resolved; pt later recovered
This spontaneous report was received from a physician via a medical assistant refers to a 60 year old female patient with no drug allergies. Current conditions included asthma, hypertension and hyperlipidemia. The patient's medical history included chickenpox (when she was 4 year old) and shingles (when she was 18 years old). On 19-SEP-2013 the patient was vaccinated with 0.65 milliliter (ml) ZOSTAVAX (lot #J003483, expiration date 29-JUN-2014) subcutaneously. Concomitant therapies included SUDAFED, ALEVE, cranberry, VENASTAT and vitamins (unspecified) (also reported as multivitamins). Patient sought medical attention at the provider's office. Patient reported to physician that rash began on 29-SEP-2013. Medical assistant reported from the notes of physician, that patient had a rash on her left, lateral and left, anterior chest and also had a rash on her mid back. The patient had spread and was painful. Physician was placed on the call to give more details of the adverse event. The physician described the rash as smooth domed, multiple clusters of red papules along dermatome line, mild look and an attenuated outbreak. The patient was treated with acetaminophen, VICODIN and VALTREX. Laboratory diagnostic studies were not performed for the event. Outcome of the event was unknown. Causality was not reported. Additional information has been requested.
my daughter who has a heart murmur was down 14 days after the first one; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (my daughter who has a heart murmur was down 14 days after the first one) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included Shingles, Sleep disorder (inability to sleep on her left side.) and Dizziness. Concurrent medical conditions included Heart murmur and Osteopenia.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (my daughter who has a heart murmur was down 14 days after the first one). At the time of the report, MALAISE (my daughter who has a heart murmur was down 14 days after the first one) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Sep-2021: Non-significant follow up include no new information.
Patient arrived for her first dose of pfizer covid vaccine. She received it at 1708 in the left deltoid and, was escorted to the 15 minute observation area.  She noted feeling burning sensation in her chest and bilateral arms after a few minutes. Patient brought to EMS for evaluation.   EMS obtained several sets of vital signs, notable for hypertension (170's/90's).  Patient placed on stretcher. She was flushed, had a dry/thick tongue, developed rash on bilateral arms, began shaking and shivering but stated she was not cold only nervous. She was given 50 mg benadryl IM, 18 g IV started in her right antecubital. She declined solumedrol due to past experience with steroids. Her flushing and rash began to resolve, patient stated her tongue felt better. Patient was transported by EMS for evaluation. She had her phone with her, but her husband took her other belongings and will meet her there.
Pt recvd vax 24APR92 & the next day devel a rash, hot flashes, lethargy & malaise; 3 months p/vax devel severe peripheral edema of legs & feet; Lab eval showed proteinuria;
pT recv vax on 8/28/98; on 9/3/98 pt exp headache, malaise, temp (99 degrees). Pt sxs incr in intensity; pt exp blurred vision.  On 9/6/98 pt seen in E.R.  On 9/7/98 pt exp shortness of breath; seen in E.R. 9/7/98.
Within 5 minutes of receiving vaccine I became diaphoretic, nauseated, dizzy, hypertensive, and tachycardic
p/vax pt c/o soreness of arm;used ice pack for pain;bruising since 11/2/99;11/4/99 pt broke out in hives all over body w/itching;advised to go to ER;
This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Had some fatigue after her 1st booster dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034F21A, 017B21A and 010A21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Had some fatigue after her 1st booster dose). At the time of the report, FATIGUE (Had some fatigue after her 1st booster dose) outcome was unknown. No concomitant medications were provided. Patient had received the first booster dose. No treatment medications were reported. This case was linked to MOD-2022-537773, MOD-2022-537798 (Patient Link).